Thus, our results would suggest the potential benefit of invasive or non-invasive anatomical assessment in patients with acute myocardial injury if coronary anatomy is unknown, followed by coronary-specific preventative therapies such as HMG-CoA reductase inhibitors to mitigate their risk for subsequent coronary events. The gene discussed is HMGCR; the disease is injury.